Cost-effectiveness of self-management in asthmatics: a 1-yr follow-up randomized, controlled trial Source: Eur Respir J 2001; 17: 206-213 Year: 2001
RCT Abstract - Using a smartphone application in COPD patients to increase physical activity following pulmonary rehabilitation. Results of the AMOPUR Study, a multicenter, randomized, controlled study Source: Virtual Congress 2021 – A multidisciplinary approach to the management of chronic respiratory diseases Year: 2021
Run-in bias in randomised trials: the case of COPD medications Source: Eur Respir J, 49 (6) 1700361; 10.1183/13993003.00361-2017 Year: 2017
A self-management programme for COPD: a randomised controlled trial Source: Eur Respir J 2014; 44: 1538-1547 Year: 2014
Medical quality control intervention for COPD patients in China: a cluster randomized, controlled trial Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020
Clinical effectiveness of self-management of asthma in general practice: a randomized controlled trial Source: Eur Respir J 2001; 18: Suppl. 33, 518s Year: 2001
Effectiveness of a pharmacist intervention for asthma control improvement: randomised controlled trial Source: Annual Congress 2007 - Delivering respiratory care: the challenges for primary care Year: 2007
An education program for asthma and COPD patients conducted by a general practice assistant; a randomised controlled trial Source: Eur Respir J 2002; 20: Suppl. 38, 396s Year: 2002
A non-interventional observational trial to study the COPD treatment choices in routine clinical practice in Bulgaria Source: International Congress 2016 – COPD diagnosis and management Year: 2016
Efficacy and costs of telehealth for the management of COPD: PROMETE II, a multicentre, randomized controlled trial Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care Year: 2017
Outcomes reported on the management of COPD exacerbations: a systematic survey of randomised controlled trials Source: ERJ Open Res, 5 (2) 00072-2019; 10.1183/23120541.00072-2019 Year: 2019
Azithromycin for treatment of hospitalised COVID-19 patients: a randomised, multicentre, open-label clinical trial (DAWn-AZITHRO) Source: ERJ Open Res, 8 (1) 00610-2021; 10.1183/23120541.00610-2021 Year: 2022
Clinical effect on asthma control using a novel digital self-management solution: a physician blinded randomized controlled crossover trial Source: International Congress 2019 – Medical education to improve practice Year: 2019
TargetCOPD: A pragmatic randomised controlled trial of targeted case finding for COPD versus routine practice in primary care Source: International Congress 2015 – Diagnosing and management of COPD in primary care Year: 2015
A trial like ALIC4 E: why design a platform, response-adaptive, open, randomised controlled trial of antivirals for influenza-like illness? Source: ERJ Open Res, 4 (2) 00046-2018; 10.1183/23120541.00046-2018 Year: 2018
Multidimensional assessment and targeted therapy of severe asthma: a randomised controlled trial (RCT) Source: International Congress 2017 – Many faces of asthma assessment Year: 2017
Late Breaking Abstract - A randomised, double-blind, placebo controlled, clinical trial evaluating imatinib in patients with severe COVID-19 Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19 Year: 2021
A randomized controlled trial on office spirometry in asthma and COPD in standard general practice: the SPACE Italian study Source: Eur Respir J 2005; 26: Suppl. 49, 670s Year: 2005
Exacerbation action plans for patients with COPD and comorbidities: a randomised controlled trial Source: Eur Respir J, 54 (5) 1802134; 10.1183/13993003.02134-2018 Year: 2019
Cost-benefit and cost-effectiveness analysis of self-management in patients with COPD - a one-year follow-up randomised, controlled trial Source: Eur Respir J 2002; 20: Suppl. 38, 67s Year: 2002